A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas

NCT00045708 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

57

Enrollment

NIH

Sponsor class

Conditions

Adult Anaplastic Astrocytoma
Adult Giant Cell Glioblastoma
Adult Gliosarcoma
Recurrent Adult Brain Tumor

Interventions

DRUG: ixabepilone
OTHER: pharmacological study
DRUG: Anticonvulsant

Sponsor

National Cancer Institute (NCI)